Results 261 to 270 of about 76,888,029 (302)

Updated COVID‐19 Vaccines and Health Outcomes in Patients With Autoimmune Rheumatic Conditions

open access: yesArthritis &Rheumatology, EarlyView.
Objective We aimed to assess the association between COVID‐19 vaccination status and COVID‐19‐related hospital admissions, need for mechanical ventilation or extracorporeal membrane oxygenation (ECMO), and death in people with autoimmune rheumatic conditions. Methods We conducted a retrospective cohort study using National Clinical Cohort Collaborative
Lesley E. Jackson   +127 more
wiley   +1 more source

Mitochondria in SARS-CoV-2 infection: Immune interactions and molecular approaches in the Post COVID-19 condition. [PDF]

open access: yesGenet Mol Biol
Barros MC   +9 more
europepmc   +1 more source

Rheumatology Informatics System for Effectiveness Registry Participation Associated With Significant Gains in Quality Measure Performance: An Interrupted Time Series Analysis

open access: yesArthritis &Rheumatology, EarlyView.
Objective To examine the association between participation in a qualified clinical data registry and quality measure performance. Methods We included practices that joined the American College of Rheumatology's Rheumatology Informatics System for Effectiveness (RISE) registry between 2015 and 2021.
Gabriela Schmajuk   +5 more
wiley   +1 more source

Risk factors of post-COVID-19 symptoms, a cross-sectional study in patients with asthma and chronic obstructive lung disease. [PDF]

open access: yesNPJ Prim Care Respir Med
Andreason A   +9 more
europepmc   +1 more source

Higher risk of Long COVID among patients with autoimmune rheumatic diseases and immunomodulatory therapy: a retrospective cohort analysis of national US data.

open access: yesArthritis &Rheumatology, Accepted Article.
Background Little is known about the prevalence of and factors associated with Long COVID in patients with autoimmune rheumatic diseases (AIRDs). Methods We conducted a retrospective cohort study using data from the National Clinical Cohort Collaborative (N3C).
Namrata Singh   +11 more
wiley   +1 more source

Opioid Overdose-Related Emergency Department Visits Pre- and Post-COVID-19. [PDF]

open access: yesWest J Emerg Med
Molina MF   +4 more
europepmc   +1 more source

Sustained Inhibition of Structural Damage Progression and Improvements in Disease Activity With Guselkumab in Biologic‐Naïve Participants with Active and Erosive Psoriatic Arthritis: Results Through Week 48 of the Phase 3b Randomized, Double‐Blind, Placebo‐Controlled APEX Study

open access: yesArthritis &Rheumatology, Accepted Article.
Objective In APEX, guselkumab, which binds to the IL‐23p19 subunit and CD64 on IL‐23‐producing cells, demonstrated significant joint efficacy and inhibition of structural damage progression in participants with active and erosive PsA through Week (W)24; W48 findings are reported herein. Methods The APEX modified full analysis set included 1020 biologic‐
Christopher T. Ritchlin   +12 more
wiley   +1 more source

Characterising Pain in Post-COVID-19 Syndrome: An Observational Study of Intensity and Sensitivity. [PDF]

open access: yesDiagnostics (Basel)
Pérez-Gisbert L   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy